LUND, SE / ACCESS Newswire / April 28, 2026 / Alligator Bioscience (STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, will publish its ...
STOCKHOLM, SE / ACCESS Newswire / April 28, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 28th, its report for the first quarter.Financial Performance in SummaryThe ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
Sample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration ...
Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a leading middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, today ...
AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one ...
Programmable circRNA platform achieves near-complete B cell depletion in non-human primates using targeted in vivo CAR-T deliveryBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage ...
Features company’s patented SimpliSqueeze® valve for ready-to-dispense convenience, focused on reducing mess and dripsCRYSTAL ...
Oral presentation will highlight new interim clinical data from the ongoing POLARIS studies; additional posters showcase broader platform capabilities -SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
Toshiba and the National Science Teaching Association (NSTA) honor student innovation with prizes and award ceremony in Washington, D.C.
GARDEN GROVE, CA / ACCESS Newswire / April 27, 2026 / Recovery Beach, a premier detox and residential treatment facility near Anaheim, California, is reopening April 27th with a new Executive Director ...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.The proposed transaction may contain terms that could limit superior competing offers.Shareholders ...